The impact of HLA class I and EBV latency-II antigen-specific CD8+ T cells on the pathogenesis of EBV+ Hodgkin lymphoma
Kimberley Jones(QIMR Berghofer Medical Research Institute), Maher K. Gandhi(Translational Research Institute), Brekhna Hassan(Cardiff University), Konrad Beck(Goethe University Frankfurt), David K. Cole(Immunocore (United Kingdom)), Pratip K. Chattopadhyay(National Institute of Allergy and Infectious Diseases), Frank Vari(The University of Queensland), Leesa Wockner(Johannes Gutenberg University Mainz), Scott R. Burrows(Australian National University), David Ritchie(Peter MacCallum Cancer Centre), John F. Seymour(The Royal Melbourne Hospital), Colm Keane(The University of Queensland), Mario Roederer(National Institutes of Health), David A. Price(University Hospital of Wales), Pauline Crooks(QIMR Berghofer Medical Research Institute), R.M. Brennan(University College Cork), David Gottlieb(The University of Sydney)
Cited by 45
Related Papers
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
|Nature Medicine|2006|3.6k
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
|Nature Medicine|2013|3k
A human memory T cell subset with stem cell–like properties
|Nature Medicine|2011|2k
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.9k
CD4+ T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract
|The Journal of Experimental Medicine|2004|1.8k